EMAIL THIS PAGE TO A FRIEND

Chinese medical journal

Angiogenesis effect of Astragalus polysaccharide combined with endothelial progenitor cells therapy in diabetic male rat following experimental hind limb ischemia.


PMID 24890165

Abstract

Diabetes mellitus (DM) is a common disease accompanied with a high incidence of hind limb ischemia (HLI). In recent years, numerous studies demonstrated that endothelial progenitor cells (EPCs) are involved in angiogenesis and maintenance of vascular integrity following HLI. On the other side, it has been proved that Astragalus polysaccharide (APS) could promote angiogenesis. In the present study, we aimed to evaluate the effect of APS and EPCs on enhancing angiogenesis after experimental HLI caused by femoral artery ligation in rats with streptozotocin (STZ)-induced diabetes. Rats (n = 110) were randomly assigned to the following groups: sham group, ischemia group, APS group, EPCs group and APS+EPCs group. APS, EPCs or an equal volume of vehicle was administered intramuscularly after HLI induction, and 6 rats were assessed by angiography at 28 days after induction of HLI, 6 rats were sacrificed at the same time point to take histological studies, biochemical tests were also performed at that point in the rest rats. APS or EPCs treatment induced an increase, respectively, in the protein expression of vascular endothelial growth factor (VEGF) (36.61%, 61.59%), VEGF receptor-1 (VEGFR-1) (35.50%, 57.33%), VEGFR-2 (31.75%, 41.89%), Angiopoietin-1 (Ang-1) (37.57%, 64.66%) and Tie-2 (42.55%, 76.94%) (P < 0.05), after HLI injury. And combined therapy of APS and EPCs enhanced the effort of angiogenesis after HLI induction in diabetic rats, through elevating protein expression of VEGF (99.67%), VEGFR-1 (105.33%), VEGFR2 (72.05%), Ang-1 (114.30%) and Tie-2 (111.87%) (P < 0.05). Similarly, mRNA expression of VEGF, VEGFR-1, VEGFR2, Ang-1, Tie-2 also show similar trends as well as protein expression (P < 0.05). APS or EPCs could enhance angiogenesis, and the combined treatment leads to better effort, at least, partially via VEGF/VEGFR and Ang-1/Tie-2 signaling pathway.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A1104 Anti-Angiopoietin-1 antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB2501978
Anti-ANGPT1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA018793
Anti-ANGPT1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA018816
Anti-ANGPT1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
SAB2107757
Anti-ANGPT1 antibody produced in rabbit, affinity isolated antibody
GW10811F Anti-CD34 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4300690
Anti-CD34 antibody produced in rabbit, affinity isolated antibody
SAB1406243
Anti-PECAM1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1408616
Anti-PECAM1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1412072
ANTI-TEK antibody produced in mouse, clone 2D2, purified immunoglobulin, buffered aqueous solution
SAB1412073
ANTI-TEK antibody produced in mouse, clone 3C1, purified immunoglobulin, buffered aqueous solution
SAB1412074
ANTI-TEK antibody produced in mouse, clone 1G10, purified immunoglobulin, buffered aqueous solution
SAB1412075
ANTI-TEK antibody produced in mouse, clone 2D7, purified immunoglobulin, buffered aqueous solution
SAB1412076
ANTI-TEK antibody produced in mouse, clone 6G9, purified immunoglobulin, buffered aqueous solution
SAB1412077
ANTI-TEK antibody produced in mouse, clone 5G6, purified immunoglobulin, buffered aqueous solution
SAB1412078
ANTI-TEK antibody produced in mouse, clone 2G2, purified immunoglobulin, buffered aqueous solution
SAB1412265
ANTI-TEK antibody produced in mouse, clone 4G9, purified immunoglobulin, buffered aqueous solution
SAB1412266
ANTI-TEK antibody produced in mouse, clone 2G3, purified immunoglobulin, buffered aqueous solution
SAB1412267
ANTI-TEK antibody produced in mouse, clone 4C4, purified immunoglobulin, buffered aqueous solution
SAB1412268
ANTI-TEK antibody produced in mouse, clone 4G10, purified immunoglobulin, buffered aqueous solution
A0604 Monoclonal Anti-Angiopoietin-1 antibody produced in mouse, clone 171718, purified immunoglobulin
SAB4700463
Monoclonal Anti-CD31 antibody produced in mouse, clone MEM-05, purified immunoglobulin, buffered aqueous solution
WH0000947M1
Monoclonal Anti-CD34 antibody produced in mouse, clone 5F3, purified immunoglobulin, buffered aqueous solution
SAB1403649
Monoclonal Anti-CD34 antibody produced in mouse, clone 5A6, purified immunoglobulin, buffered aqueous solution
SAB4700160 Monoclonal Anti-CD34 antibody produced in mouse, clone 4H11[APG], purified immunoglobulin, buffered aqueous solution
SAB4700736 Monoclonal Anti-CD34 antibody produced in mouse, clone 581, purified immunoglobulin, buffered aqueous solution
WH0005175M1
Monoclonal Anti-PECAM1 antibody produced in mouse, clone 1D2-1A5, purified immunoglobulin, buffered aqueous solution
WH0007010M2
Monoclonal Anti-TEK antibody produced in mouse, clone 3F8, purified immunoglobulin, buffered aqueous solution
SAB1404458
Monoclonal Anti-TEK antibody produced in mouse, clone 1A4, purified immunoglobulin, buffered aqueous solution